Skip to main content
. 2022 Oct 28;44(4):293–300. doi: 10.1093/eurheartj/ehac577

Figure 1.

Figure 1

Association of baseline log-transformed growth differentiation factor 15 (per 1 standard deviation) with cardiovascular outcomes. MACE, major adverse cardiac events; CV, cardiovascular; HHF, hospitalization for heart failure; MI, myocardial infarction; HR, hazard ratio; CI, confidence interval. Hazard ratio adjusted for clinical factors and other biomarkers. An increase in 1 standard deviation of log growth differentiation factor 15 was independently associated with all the cardiovascular endpoints (P-value all <0.005).

HHS Vulnerability Disclosure